New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
06:41 EDTMDCOThe Medicines Co. price target raised to $37 from $34 at Leerink
Leerink raised its price target for The Medicines Co. after the company announced positive Phase 3 results of the PHOENIX trial of Cangrelor. The firm estimates Cangrelor could address a $200M U.S. market opportunity and reiterates an Outperform rating on the stock.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 3, 2016
08:33 EDTMDCOThe Medicines Co. names Alexander Denner to board
Subscribe for More Information
February 1, 2016
08:51 EDTMDCOThe Medicines Co. completes divestiture of hemostasis portfolio to Mallinckrodt
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use